Retatrutide 20mg Pen

Retatrutide 20mg Pen is an investigational peptide supplied in a pre-filled, sterile multi-dose pen formulation intended for controlled laboratory or research use only. It is a long-acting triple receptor agonist that targets GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors, which are pathways involved in metabolic regulation and energy balance.

Each pen contains 20mg of Retatrutide in a ready-to-use liquid formulation designed for accurate and consistent dosing in research settings. Due to its extended half-life (approximately one week in studied models), it is commonly evaluated in once-weekly experimental protocols.

Retatrutide is currently an investigational compound and is not approved for therapeutic use, prescription use, or human consumption outside clinical trials. All handling and storage should comply with applicable research regulations and laboratory safety standards.